Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL

Liping Li, MD PhD, Katharina Hayer, Lingling Xian, MD PhD, Li Luo, PhD, Leslie Cope, Andrei Thomas-Tikhonenko, PhD, Linda Resar, MD

Blood (2019) 134 (Supplement_1): 3946.

https://doi.org/10.1182/blood-2019-130261

Published: 2019

Journal Articles

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Blood (2019) 134 (Supplement_1): 1351.

https://doi.org/10.1182/blood-2019-126523

Published: 2019

Journal Articles

Genetic Evidence for Involvement of Human Endogenous Retrovirus Herv-Fc1 in the Pathogenesis of MPNs

Vibe Skov, PhD, Katrine LM Schmidt, Kasper Mønsted Pedersen, MD, Bettina Hansen, Tobias Wirenfeldt Klausen, M.S., Torben A Kruse, Mads Thomassen, PhD, Lasse Kjær, PhD, Christina Ellervik, Associate Professor, MD PhD, Morten Holmstrøm, MD, Bjørn Nexø, Hans Carl Hasselbalch, Professor, dr.MD, Magdalena J Laska

Blood (2018) 132 (Supplement 1): 5488.

https://doi.org/10.1182/blood-2018-99-118080

Published: 2018

Journal Articles

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Blood (2018) 132 (21): 2280–2285.

https://doi.org/10.1182/blood-2018-03-842088

Published: 2018

Includes: Supplemental data

Journal Articles

Time Points, Dynamics and Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with NPM1 mutation: A Study on 428 Patients

Torsten Haferlach, MD, Claudia Haferlach, MD, Wenke Worseg, Karolína Perglerová, Wolfgang Kern, MD, Manja Meggendorfer, PhD

Blood (2016) 128 (22): 1710.

https://doi.org/10.1182/blood.V128.22.1710.1710

Published: 2016

Journal Articles

Activation Induced Cytidine Deaminase (Aid) Acts As a Gate Keeper in Pro-B Cells and Prevents PB-ALL

Franziska Auer, MSc, Deborah Ingenhag, MSc, Isidro Sánchez-García, MD, Arndt Borkhardt, MD, Julia Hauer, MD

Blood (2016) 128 (22): 1538.

https://doi.org/10.1182/blood.V128.22.1538.1538

Published: 2016

Journal Articles

CLL2-BIG - a Novel Treatment Regimen of Bendamustine Followed By GA101 and Ibrutinib Followed By Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Phase II-Trial

Julia von Tresckow, MD, Paula Cramer, MD, Jasmin Bahlo, Sandra Robrecht, Anja Engelke, MD, Petra Langerbeins, MD, Anna-Maria Fink, MD, Thomas Illmer, MD, Holger Klaproth, MD, Sven Estenfelder, Matthias Ritgen, Kirsten Fischer, MD, Clemens-Martin Wendtner, MD, Karl-Anton Kreuzer, MD, Stephan Stilgenbauer, Sebastian Böttcher, Barbara Eichhorst, MD, Michael Hallek

Blood (2016) 128 (22): 640.

https://doi.org/10.1182/blood.V128.22.640.640

Published: 2016

Journal Articles

Frequency of CTLA-4 Receptor Ligand (CD86, B7.2) -Positive Plasmacytoid Dendritic Cells Predicts Risk of Disease Recurrence after Tyrosine-Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Results from a Prospective Substudy of the Euroski Trial

Blood (2015) 126 (23): 599.

https://doi.org/10.1182/blood.V126.23.599.599

Published: 2015

Journal Articles

A New ETV6-RUNX1 In Vivo Model Produces a Phenocopy of the Human Pb-ALL

Blood (2015) 126 (23): 3658.

https://doi.org/10.1182/blood.V126.23.3658.3658

Published: 2015

Journal Articles

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Torsten Haferlach, Manja Meggendorfer, PhD, Susanne Schnittger, PhD, Annette Fasan, PhD, Wolfgang Kern, MD, Claudia Haferlach, MD

Blood (2015) 126 (23): 228.

https://doi.org/10.1182/blood.V126.23.228.228

Published: 2015

Journal Articles

Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype

Claudia Haferlach, MD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2015) 126 (23): 1674.

https://doi.org/10.1182/blood.V126.23.1674.1674

Published: 2015

Journal Articles

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Eva Rettinger, MD, Michael Merker, MD, Hermann Kreyenberg, PhD, Thomas Krenn, MD, Matthias Dürken, MD, Jörg Faber, MD PhD, Sabine Huenecke, PhD, Claudia Brehm, PhD, Melanie Bremm, PhD, Shahrzad Bakhtiar, MD, Andre Manfred Willasch, MD, Andrea Jarisch, MD, Jan Soerensen, MD, Thomas Klingebiel, Prof., Peter Bader

Blood (2014) 124 (21): 3953.

https://doi.org/10.1182/blood.V124.21.3953.3953

Published: 2014

Journal Articles

Selective Expansion of Regulatory T-Cells during Lenalidomid Treatment of MDS with Isolated Deletion 5q

Martin Wermke, MD, Claudia Schuster, Claudia Schönefeldt, Sebastian Tuve, MD, Gerhard Ehninger, MD, Detlef Haase, Ulrich Germing, MD, Martin Bornhäuser, MD, Uta Oelschlaegel, PhD, Malte von Bonin, MD, Uwe Platzbecker, MD

Blood (2014) 124 (21): 4654.

https://doi.org/10.1182/blood.V124.21.4654.4654

Published: 2014

Journal Articles

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Marius Rohde, Martin Zimmermann, Bettina R. Bonn, Monika Szczepanowski, Ilske Oschlies, Wolfram Klapper, MD, Anja Möricke, Martin Schrappe, Inga Nagel, Reiner Siebert, Alfred Reiter, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2980.

https://doi.org/10.1182/blood.V124.21.2980.2980

Published: 2014

Journal Articles

Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment

Giada Biddeci, Giovanna Sanna, Giulia Geranio, Stefania Varotto, MD, Elena Varotto, Maria Gabelli, Mariagrazia Petris, Sara Maggiolo, Elena Campello, Maria Bon, Paolo Simioni, Luca Spiezia, Sartori Maria Teresa, Giuseppe Basso, Maria Caterina Putti

Blood (2014) 124 (21): 5246.

https://doi.org/10.1182/blood.V124.21.5246.5246

Published: 2014

Journal Articles

Monitoring By Chromosome Banding Analysis (CBA) and FISH Of Circulating CD34+ Cells In Low-Risk MDS Patients Treated In The Le-Mon-5 Study With Lenalidomide Monotherapy Reveals 82% Cytogenetic Responders With Different Response – , Evolutionary -, and Remission Patterns and No Increased Karyotype Evolution (KE)

Katayoon Shirneshan, PhD, Uwe Platzbecker, MD, PhD, Florian Nolte, MD, Aristoteles Giagounidis, MD, Katharina Götze, M.D., Richard F. Schlenk, MD, Michael Lübbert, MD, Gesine Bug, MD, PhD, Friederike Braulke, Julie Schanz, MD, Ulrich Germing, MD, Detlef Haase, MD

Blood (2013) 122 (21): 2783.

https://doi.org/10.1182/blood.V122.21.2783.2783

Published: 2013

Journal Articles

Activity Of Single Agent Temsirolimus and Associated Impact On Bone Marrow Vascularization and T-Cell Composition In Patients With Myelodysplastic Syndromes – Result Of The Prospective Temds Trial Of The German MDS-SG

Martin Wermke, MD, Claudia Schuster, Claudia Schönefeldt, Christiane Jakob, MD, Malte von Bonin, MD, Florian Nolte, MD, Philipp Kiewe, MD, Regina Herbst, MD, Ulrich Germing, MD, Michael Aigner, PhD, Detlef Haase, MD, Ina-Maria Klut, PhD, Nadja Jaekel, Gustavo Baretton, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Wolf-Karsten Hofmann, MD, Uwe Platzbecker, MD, PhD

Blood (2013) 122 (21): 2808.

https://doi.org/10.1182/blood.V122.21.2808.2808

Published: 2013

Journal Articles

The Immunologic Composition of the Bone Marrow Changes Rapidly During the Harvest Procedure

Martin Wermke, MD, Cathrin Wegner, Malte von Bonin, MD, Sebastian Tuve, MD, Claudia Schönefeldt, MSc, Kristina Hölig, MD, Uta Oelschlegel, PhD, Martin Bornhaeuser, MD, Uwe Platzbecker, MD, Rainer Ordemann, MD

Blood (2012) 120 (21): 1915.

https://doi.org/10.1182/blood.V120.21.1915.1915

Published: 2012

Journal Articles

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

Markus Ertmer, Djordje Atanackovic, Lucia Vankann, Stefan Wilop, MD, Eray Gökkurt, MD, Tim H Brümmendorf, Jens Panse, MD

Blood (2012) 120 (21): 4969.

https://doi.org/10.1182/blood.V120.21.4969.4969

Published: 2012

Journal Articles

High CD45 (PTPRC) Expression Is Associated with An Overall Poor Outcome in Childhood Acute Lymphoblastic Leukemia Treated on the ALL-BFM 2000 Protocol and Exerts An Especially Pronounced Effect in Intermediate Risk Patients

Gunnar Cario, MD, Rita Mitlohner, Martin Zimmermann, PhD, Renja Romey, Peter Rhein, PhD, André Schrauder, MD, Anja Moericke, MD, Jean-Pierre Bourquin, MD, PhD, Wolf-Dieter Ludwig, MD, Richard Ratei, MD, Martin Schrappe, MD, Leonid Karawajew, PhD, Martin Stanulla, MD, MSc

Blood (2011) 118 (21): 742.

https://doi.org/10.1182/blood.V118.21.742.742

Published: 2011

NARROW

High Mobility Group A1 Chromatin Regulators Function As Critical Drivers of Leukemogenesis in Preclinical Models of Relapsed, Pediatric B-Cell ALL

Poor Prognosis in Children with ABL -Class Fusion Positive B-Cell Acute Lymphoblastic Leukemia Treated According to AIEOP-BFM Protocols

Genetic Evidence for Involvement of Human Endogenous Retrovirus Herv-Fc1 in the Pathogenesis of MPNs

IG- MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas

Time Points, Dynamics and Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with NPM1 mutation: A Study on 428 Patients

Activation Induced Cytidine Deaminase (Aid) Acts As a Gate Keeper in Pro-B Cells and Prevents PB-ALL

CLL2-BIG - a Novel Treatment Regimen of Bendamustine Followed By GA101 and Ibrutinib Followed By Ibrutinib and GA101 Maintenance in Patients with Chronic Lymphocytic Leukemia (CLL): Results of a Phase II-Trial

Frequency of CTLA-4 Receptor Ligand (CD86, B7.2) -Positive Plasmacytoid Dendritic Cells Predicts Risk of Disease Recurrence after Tyrosine-Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Results from a Prospective Substudy of the Euroski Trial

A New ETV6-RUNX1 In Vivo Model Produces a Phenocopy of the Human Pb-ALL

Clinical Impact of Minimal Residual Disease (MRD) Monitoring in AML with PM - Rara , CBFB - MYH11 , and RUNX1 - RUNX1T1 : A Study on 600 Patients

Characterization of CMML with Normal Karyotype in Comparison to CMML with Aberrant Karyotype

Long-Term Outcome of Preemptive Immunotherapy Based on Post-Transplant Chimerism and MRD Monitoring after Allogeneic Stem Cell Transplantation in Children with Acute Lymphoblastic Leukemia: A Single Center Experience

Selective Expansion of Regulatory T-Cells during Lenalidomid Treatment of MDS with Isolated Deletion 5q

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Antithrombin Plasma Levels and Fibtem Determination in Children with Acute Lymphoblastic Leukemia Undergoing Asparaginase Treatment

Activity Of Single Agent Temsirolimus and Associated Impact On Bone Marrow Vascularization and T-Cell Composition In Patients With Myelodysplastic Syndromes – Result Of The Prospective Temds Trial Of The German MDS-SG

The Immunologic Composition of the Bone Marrow Changes Rapidly During the Harvest Procedure

Identification of Atypical Plasma Cells in Patients with MGUS or Multiple Myeloma Through Expression of Immunoreceptor CD229

High CD45 (PTPRC) Expression Is Associated with An Overall Poor Outcome in Childhood Acute Lymphoblastic Leukemia Treated on the ALL-BFM 2000 Protocol and Exerts An Especially Pronounced Effect in Intermediate Risk Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only